These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 15341812)

  • 1. Pharmacologic management of urinary incontinence.
    Thomas DR
    Clin Geriatr Med; 2004 Aug; 20(3):511-23, vii-viii. PubMed ID: 15341812
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Medical management of urinary incontinence.
    Diokno AC
    Gastroenterology; 2004 Jan; 126(1 Suppl 1):S77-81. PubMed ID: 14978642
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacologic management of urinary incontinence in the female.
    Rovner ES; Wein AJ
    Minerva Ginecol; 2004 Aug; 56(4):327-47. PubMed ID: 15377982
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Treatment of urinary incontinence in the elderly woman].
    Liedl B
    MMW Fortschr Med; 2005 Nov; 147(45):48-50. PubMed ID: 16320653
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Emerging drugs for treatment of urinary incontinence.
    Vij M; Robinson D; Cardozo L
    Expert Opin Emerg Drugs; 2010 Jun; 15(2):299-308. PubMed ID: 20384545
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Drug treatment options in urinary incontinence.
    Wells M
    Community Nurse; 2000 Feb; 6(1):11-2. PubMed ID: 11144190
    [No Abstract]   [Full Text] [Related]  

  • 7. [Anticholinergic drugs in overactive bladder].
    Muhlstein J; Deval B
    Gynecol Obstet Fertil; 2008 Jan; 36(1):90-6. PubMed ID: 18178506
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Overactive bladder syndrome in older people.
    Wagg AS; Cardozo L; Chapple C; De Ridder D; Kelleher C; Kirby M; Milsom I; Vierhout M
    BJU Int; 2007 Mar; 99(3):502-9. PubMed ID: 17407511
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Short- and long-term efficacy of solifenacin treatment in patients with symptoms of mixed urinary incontinence.
    Staskin DR; Te AE
    BJU Int; 2006 Jun; 97(6):1256-61. PubMed ID: 16686722
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatments for stress urinary incontinence.
    Anders K
    Nurs Times; 2006 Jan 10-16; 102(2):55-7. PubMed ID: 16429695
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Solifenacin for overactive bladder with incontinence: symptom bother and health-related quality of life outcomes.
    Garely AD; Lucente V; Vapnek J; Smith N
    Ann Pharmacother; 2007 Mar; 41(3):391-8. PubMed ID: 17341526
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Urinary incontinence: selected current concepts.
    Wilson MM
    Med Clin North Am; 2006 Sep; 90(5):825-36. PubMed ID: 16962844
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Urinary incontinence: new pharmacologic therapies].
    Robles García JE; Zudaire Bergera JJ; Rosell Costa D; Berián Polo JM
    Rev Med Univ Navarra; 2004; 48(4):43-9. PubMed ID: 15812946
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oxybutynin transdermal system improves the quality of life in adults with overactive bladder: a multicentre, community-based, randomized study.
    Sand P; Zinner N; Newman D; Lucente V; Dmochowski R; Kelleher C; Dahl NV
    BJU Int; 2007 Apr; 99(4):836-44. PubMed ID: 17187655
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Overactive bladder: treatment options for the aging woman.
    Park SH; Davila GW
    Int J Fertil Womens Med; 2005; 50(1):37-44. PubMed ID: 15971720
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Drug therapy in urinary incontinence and/or bladder emptying problems].
    Møller LA; Abel I; Thyssen H; Sander P; Mouritsen L; Lose G; Sørensen C; Philipsen J; Ottesen M; Rasmussen FA; Topp M; Larsen J; Gimbel H
    Ugeskr Laeger; 2006 Jun; 168(26-32):2580-1; author reply 2581. PubMed ID: 16824423
    [No Abstract]   [Full Text] [Related]  

  • 17. Mixed urinary incontinence: continuing to confound?
    Hockey J
    Curr Opin Obstet Gynecol; 2007 Dec; 19(6):521-8. PubMed ID: 18007128
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Design of the Behavior Enhances Drug Reduction of Incontinence (BE-DRI) study.
    Urinary Incontinence Treatment Network (UITN)
    Contemp Clin Trials; 2007 Jan; 28(1):48-58. PubMed ID: 16919506
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Improving the global management of the neurogenic bladder patient: part II. Future treatment strategies.
    Denys P; Corcos J; Everaert K; Chartier-Kastler E; Fowler C; Kalsi V; Nitti V; Schulte-Baukloh H; Schurch B
    Curr Med Res Opin; 2006 May; 22(5):851-60. PubMed ID: 16709307
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Patients with overactive bladders deserve better.
    Brenner B; Rice M
    N Z Med J; 2006 Feb; 119(1229):U1846. PubMed ID: 16498474
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.